Review of flavopiridol, a cyclin-dependent kinase inhibitor, as breast cancer therapy

被引：28
|
作者：
Tan, AR [1 ]
Swain, SM [1 ]
机构：
[1] NCI, Canc Therapeut Branch, Canc Res Ctr, Bethesda, MD 20899 USA
来源：
SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 03期
关键词：
D O I：
10.1053/sonc.2002.34059
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：77 / 85
页数：9
相关论文
共 50 条
  • [31] Place in Therapy of Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: A Targeted Literature Review
    Zhao, Melody
    Hanson, Kent A.
    Zhang, Yixie
    Zhou, Anna
    Cha-Silva, Ashley S.
    TARGETED ONCOLOGY, 2023, 18 (03) : 327 - 358
  • [32] Targeting cyclin-dependent kinase 9 in cancer therapy
    Shen, Yi-li
    Wang, Yan-mao
    Zhang, Ya-xin
    Ma, Shen-jie
    Yang, Le-he
    Zhao, Cheng-guang
    Huang, Xiao-ying
    ACTA PHARMACOLOGICA SINICA, 2022, 43 (07) : 1633 - 1645
  • [33] Differences of cyclin-dependent kinase 4/6 inhibitor, palbociclib and abemaciclib, in breast cancer
    Tamura, Kenji
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (11) : 993 - 998
  • [34] Place in Therapy of Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: A Targeted Literature Review
    Melody Zhao
    Kent A. Hanson
    Yixie Zhang
    Anna Zhou
    Ashley S. Cha-Silva
    Targeted Oncology, 2023, 18 : 327 - 358
  • [35] Targeting cyclin-dependent kinase 9 in cancer therapy
    Yi-li Shen
    Yan-mao Wang
    Ya-xin Zhang
    Shen-jie Ma
    Le-he Yang
    Cheng-guang Zhao
    Xiao-ying Huang
    Acta Pharmacologica Sinica, 2022, 43 : 1633 - 1645
  • [36] Cyclin-dependent kinase 7 inhibitors in cancer therapy
    Wang, Minmin
    Wang, Tianyu
    Zhang, Xiangyu
    Wu, Xiaoxing
    Jiang, Sheng
    FUTURE MEDICINAL CHEMISTRY, 2020, 12 (09) : 813 - 833
  • [37] Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: A University of Chicago phase II consortium study
    Stadler, WM
    Vogelzang, NJ
    Amato, R
    Sosman, J
    Taber, D
    Liebowitz, D
    Vokes, EE
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (02) : 371 - 375
  • [38] Amelioration of nephropathy in mice expressing HIV-1 genes by the cyclin-dependent kinase inhibitor flavopiridol
    Nelson, PJ
    D'Agati, VD
    Gries, JM
    Suarez, JR
    Gelman, IH
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (04) : 921 - 929
  • [39] Antitumor effects of flavopiridol, a cyclin-dependent kinase inhibitor, on human cholangiocarcinoma in vitro and in an in vivo xenograft model
    Saisomboon, Saowaluk
    Kariya, Ryusho
    Vaeteewoottacharn, Kulthida
    Wongkham, Sopit
    Sawanyawisuth, Kanlayanee
    Okada, Seiji
    HELIYON, 2019, 5 (05)
  • [40] Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma
    Schwartz, GK
    Ilson, D
    Saltz, L
    O'Reilly, E
    Tong, W
    Maslak, P
    Werner, J
    Perkins, P
    Stoltz, M
    Kelsen, D
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (07) : 1985 - 1992
12345